Barinthus Biotherapeutics Plc (BRNS) - News Archive

Strategic Shift and Financial Challenges: Barinthus Bio s Journey in Immunology and InflammationIn the rapidly evolving landscape of biopharmaceuticals, Barinthus Biotherapeutics plc, based in Oxford, UK, has recently c...

Barinthus Biotherapeutics Promotes Lynn Amid Financial Struggles: A Potential Rebirth in Hepatitis B Treatment?An Look into Barinthus Biotherapeutics and the Future of Hepatitis B TreatmentIn a surprising turn of events...

Breakthroughs in Chronic Hepatitis B Treatment: Barinthus Bio s Promising Phase 2b Trial Results Chronic Hepatitis B (CHB) continues to be a major global health challenge, with millions affected worldwide. New therapeut...

In recent developments, Barinthus Biotherapeutics plc (NASDAQ: BRNS), a pioneering clinical-stage biopharmaceutical firm, has made significant strides in its clinical programs targeting chronic hepatitis B (CHB) and pro...

Barinthus Bio Prioritizes Strategic Pipeline and Presents Positive Data for Hepatitis B Immunotherapeutic Candidate at EASL Congress 2024OXFORD, United Kingdom, May 22, 2024 - Barinthus Biotherapeutics plc (NASDAQ: BRNS...

Breakthrough in Chronic Hepatitis B Treatment: Barinthus Bio s VTP-300 Trial Results Show PromiseIn a significant leap forward in the treatment of chronic hepatitis B, Barinthus Bio s VTP-300 has demonstrated remarkable...

In a groundbreaking development, Barinthus Biotherapeutics plc (NASDAQ: BRNS) is set to present crucial clinical data updates at the highly anticipated European Association for the Study of the Liver (EASL) Congress, ta...

Barinthus Bio, known previously as Vaccitech plc and listed on the NASDAQ as BRNS, has recently announced the topline conclusive data from its APOLLO trial, alternatively referred to as HPV001. The company has created r...

Financial Update:Barinthus Bio s financial update highlights the company s strong fiscal performance over the past year. Powered by a robust product pipeline and successful commercialization efforts, Barinthus Bio repor...